Klaus Krampfl

1.4k total citations
38 papers, 1.1k citations indexed

About

Klaus Krampfl is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Klaus Krampfl has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Cellular and Molecular Neuroscience, 28 papers in Molecular Biology and 9 papers in Neurology. Recurrent topics in Klaus Krampfl's work include Neuroscience and Neuropharmacology Research (28 papers), Ion channel regulation and function (25 papers) and Nicotinic Acetylcholine Receptors Study (11 papers). Klaus Krampfl is often cited by papers focused on Neuroscience and Neuropharmacology Research (28 papers), Ion channel regulation and function (25 papers) and Nicotinic Acetylcholine Receptors Study (11 papers). Klaus Krampfl collaborates with scholars based in Germany, United Kingdom and Canada. Klaus Krampfl's co-authors include Johannes Bufler, Reinhard Dengler, Friedrich Schlesinger, Gertrud Haeseler, M. Leuwer, Jörg Ahrens, Nilufar Foadi, Jeanne de la Roche, Bahram Mohammadi and Bahram Mohammadi and has published in prestigious journals such as Annals of Neurology, International Journal of Radiation Oncology*Biology*Physics and British Journal of Pharmacology.

In The Last Decade

Klaus Krampfl

38 papers receiving 1.1k citations

Peers

Klaus Krampfl
Ike dela Peña South Korea
P. J. Langlais United States
Subbu Apparsundaram United States
Feng Tao United States
John L. Goudreau United States
Klaus Krampfl
Citations per year, relative to Klaus Krampfl Klaus Krampfl (= 1×) peers Haifeng Shu

Countries citing papers authored by Klaus Krampfl

Since Specialization
Citations

This map shows the geographic impact of Klaus Krampfl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Krampfl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Krampfl more than expected).

Fields of papers citing papers by Klaus Krampfl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus Krampfl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Krampfl. The network helps show where Klaus Krampfl may publish in the future.

Co-authorship network of co-authors of Klaus Krampfl

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus Krampfl. A scholar is included among the top collaborators of Klaus Krampfl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus Krampfl. Klaus Krampfl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roche, Jeanne de la, M. Leuwer, Klaus Krampfl, et al.. (2012). 4-Chloropropofol enhances chloride currents in human hyperekplexic and artificial mutated glycine receptors. BMC Neurology. 12(1). 104–104. 5 indexed citations
2.
Körner, Sonja, Katja Kollewe, Antonia Zapf, et al.. (2011). Onset and spreading patterns of upper and lower motor neuron symptoms in amyotrophic lateral sclerosis. Muscle & Nerve. 43(5). 636–642. 64 indexed citations
3.
Song, Yunping, et al.. (2010). Changes in extracellular pH affect glycine receptor channels expressed in HEK 293 cells. European Journal of Pharmacology. 636(1-3). 59–64. 8 indexed citations
4.
Kollewe, Katja, Lingjing Jin, Klaus Krampfl, Reinhard Dengler, & Bahram Mohammadi. (2009). Treatment of Phantom Limb Pain with Botulinum Toxin Type A: Table 1. Pain Medicine. 10(2). 300–303. 43 indexed citations
5.
Leuwer, M., Jeanne de la Roche, Klaus Krampfl, et al.. (2009). Modulation of Glycine Receptor Function by the Synthetic Cannabinoid HU210. Pharmacology. 83(5). 270–274. 20 indexed citations
6.
Song, Yunping, et al.. (2009). Synaptic currents and transmitter responses in human NT2 neurons differentiated in aggregate culture. Neuroscience Letters. 468(3). 207–210. 21 indexed citations
7.
Jin, Lingjing, Friedrich Schlesinger, Yunping Song, Reinhard Dengler, & Klaus Krampfl. (2009). The Interaction of the Neuroprotective Compounds Riluzole and Phenobarbital with AMPA-Type Glutamate Receptors: A Patch-Clamp Study. Pharmacology. 85(1). 54–62. 17 indexed citations
8.
Mohammadi, Bahram, et al.. (2007). Correlation between distal motor latency and compound muscle action potential in amyotrophic lateral sclerosis. Neurological Research. 29(5). 425–428. 5 indexed citations
9.
Maljevic, Snezana, Klaus Krampfl, Joana Cobilanschi, et al.. (2006). A mutation in the GABAA receptor α1‐subunit is associated with absence epilepsy. Annals of Neurology. 59(6). 983–987. 154 indexed citations
10.
Krampfl, Klaus, Snezana Maljevic, Patrick Cossette, et al.. (2005). Molecular analysis of the A322D mutation in the GABAA receptor α1‐subunit causing juvenile myoclonic epilepsy. European Journal of Neuroscience. 22(1). 10–20. 52 indexed citations
11.
12.
Schlesinger, Friedrich, et al.. (2005). Two mechanisms of action of the adamantane derivative IEM‐1460 at human AMPA‐type glutamate receptors. British Journal of Pharmacology. 145(5). 656–663. 20 indexed citations
13.
Dengler, Reinhard, Nils von Neuhoff, Johannes Bufler, et al.. (2005). Amyotrophic Lateral Sclerosis: New Developments in Diagnostic Markers. Neurodegenerative Diseases. 2(3-4). 177–184. 24 indexed citations
14.
Krampfl, Klaus, et al.. (2005). Effects of propofol on recombinant AMPA receptor channels. European Journal of Pharmacology. 511(1). 1–7. 8 indexed citations
15.
Haeseler, Gertrud, Jörg Ahrens, Klaus Krampfl, et al.. (2005). Structural features of phenol derivatives determining potency for activation of chloride currents via α1 homomeric and α1β heteromeric glycine receptors. British Journal of Pharmacology. 145(7). 916–925. 14 indexed citations
16.
Ahrens, Jörg, Gertrud Haeseler, M. Leuwer, et al.. (2004). 2,6 Di-tert-butylphenol, a Nonanesthetic Propofol Analog, Modulates α1β Glycine Receptor Function in a Manner Distinct from Propofol. Anesthesia & Analgesia. 99(1). 91–96. 23 indexed citations
17.
Petri, Susanne, Klaus Krampfl, Claudia Grothe, et al.. (2004). The mRNA expression of AMPA type glutamate receptors in the primary motor cortex of patients with amyotrophic lateral sclerosis: an in situ hybridization study. Neuroscience Letters. 360(3). 170–174. 8 indexed citations
18.
Großkreutz, Julian, et al.. (2003). Kinetic properties of human AMPA‐type glutamate receptors expressed in HEK293 cells. European Journal of Neuroscience. 17(6). 1173–1178. 55 indexed citations
19.
Krampfl, Klaus, Reinhard Dengler, & Johannes Bufler. (2002). Block of recombinant nicotinic receptor channels by IgG from myasthenic patients. Muscle & Nerve. 25(3). 433–437. 2 indexed citations
20.
Mohammadi, Bahram, Gertrud Haeseler, M. Leuwer, et al.. (2001). Structural requirements of phenol derivatives for direct activation of chloride currents via GABAA receptors. European Journal of Pharmacology. 421(2). 85–91. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026